Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Helius Medical Technologies, Inc. (HSDT) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$0.04M
Net Income	$-9.83M
Cost of Goods Sold	$0.10M
Gross Profit	$-0.05M
Operating Expenses	$3.37M
Operating Income	$-3.32M
Non-Operating Income/Expense	$-6.51M
Pre-Tax Income	$-9.83M
Normalized Pre-Tax Income	$-9.83M
Income after Taxes	$-9.83M
Income from Continuous Operations	$-9.83M
Consolidated Net Income/Loss	$-9.83M
Normalized Income after Taxes	$-9.83M
EBIT	$-3.32M
EBITDA	$-2.63M
Weighted-Average Shares Outstanding (Basic)	0.12M
Weighted-Average Shares Outstanding (Diluted)	0.12M
Earnings per Share (EPS) (Basic)	$-79.73
Earnings per Share (EPS) (Diluted)	$-79.73
Balance Sheet Financials
Current Assets	$7.80M
Property, Plant, and Equipment	$0.09M
Long-Term Assets	$0.09M
Total Assets	$7.89M
Current Liabilities	$1.80M
Long-Term Debt	--
Long-Term Liabilities	$0.06M
Total Liabilities	$1.87M
Common Equity	$6.03M
Tangible Shareholders Equity	$6.03M
Shareholders Equity	$6.03M
Common Shares Outstanding	0.68M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.29M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$11.28M
Beginning Cash	$1.09M
End Cash	$6.08M
Increase/Decrease in Cash	$4.99M
Stock-Based Compensation	$1.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	-123.26%
Operating Margin	-7725.58%
EBIT Margin	-7725.58%
EBITDA Margin	--
Pre-Tax Profit Margin	-22867.44%
Profit Margin	-22867.44%
Free Cash Flow	$-6.29M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.08
Receiveable Turnover	0.46
Days Sales in Receivables	196.74
Return on Equity	-163.18%
Return on Tangible Equity	-163.18%
Return on Assets	-124.58%
Return on Investments	-163.18%
Book Value Per Share	$8.86
Free Cash Flow per Share	$-51.16
Operating Cash Flow per Share	$-51.16

Data from Zacks Investment Research, Inc.